Novavax and Takeda Announce Collaboration for Novavax’ COVID-19 Vaccine Candidate in Japan

GAITHERSBURG, Md. and OSAKA, Japan, Aug. 7 (Korea Bizwire) — Novavax, Inc. (Nasdaq: NVAX), a late stage biotechnology company developing next-generation vaccines for serious infectious diseases, and Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK), today announced a partnership for the development, manufacturing and commercialization of NVX‑CoV2373, Novavax’ COVID‑19 vaccine candidate, in Japan. NVX‑CoV2373 is a stable, prefusion [...]